Evidence map›Paper›PMID 29401516›Full record

ArticlePloS one2018

Computational modelling of pathogenic protein spread in neurodegenerative diseases.

Konstantinos Georgiadis, Selina Wray, Sébastien Ourselin, Jason D Warren, Marc Modat

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mathematical Biology Models of Parkinson's Disease.CPT: pharmacometrics & systems pharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Konstantinos GeorgiadisTranslational Imaging Group, Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London NW1 2HE, United Kingdom.ORCID 0000-0003-4460-9021
Selina WrayDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
Sébastien OurselinTranslational Imaging Group, Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London NW1 2HE, United Kingdom.
Jason D WarrenDementia Research Centre, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
Marc ModatTranslational Imaging Group, Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London NW1 2HE, United Kingdom.

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013103/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013201/1Wellcome Trust
6 · The paper itself

Abstract

Pathogenic protein accumulation and spread are fundamental principles of neurodegenerative diseases and ultimately account for the atrophy patterns that distinguish these diseases clinically. However, the biological mechanisms that link pathogenic proteins to specific neural network damage patterns have not been defined. We developed computational models for mechanisms of pathogenic protein accumulation, spread and toxic effects in an artificial neural network of cortical columns. By varying simulation parameters we assessed the effects of modelled mechanisms on network breakdown patterns. Our findings suggest that patterns of network breakdown and the convergence of patterns follow rules determined by particular protein parameters. These rules can account for empirical data on pathogenic protein spread in neural networks. This work provides a basis for understanding the effects of pathogenic proteins on neural circuits and predicting progression of neurodegeneration.

Indexed as

Computer SimulationHumansNeurodegenerative DiseasesProteinsProteins

Identifiers

PMID29401516
PMCPMC5798854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.